查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球哺乳動物細胞發酵技術市場規模研究與預測（按類型、按應用、最終用途和區域分析），2023-2030 年
市場調查報告書
商品編碼
1381797

全球哺乳動物細胞發酵技術市場規模研究與預測（按類型、按應用、最終用途和區域分析），2023-2030 年

Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type, By Application, By End-use and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2022年全球哺乳動物細胞發酵技術市場價值約為394.9億美元，預計在2023-2030年預測期內將以超過8.64%的成長率成長。哺乳動物細胞發酵廣泛用於製造各種生物相似藥、酵素、疫苗和其他生物製劑。這是生物製藥發展的重要一步。哺乳動物細胞在體外由幹細胞產生後，在生物反應器中培養發酵。在此過程中，細胞透過多種代謝途徑產生重要的副產物。哺乳動物細胞發酵技術市場的推動因素包括慢性病盛行率不斷上升、對新型安全療法的需求不斷成長以及對生物製劑和生物相似藥的需求不斷成長。

此外，包括癌症在內的各種慢性疾病的盛行率不斷上升正在推動市場成長，因為癌症治療通常涉及使用單株抗體、治療蛋白和疫苗等生物製劑。哺乳動物細胞發酵是生產這些複雜生物製品的關鍵方法。由於癌症盛行率的上升，對生物製品的需求增加，這反過來又推動了對哺乳動物細胞發酵技術的需求。根據國際癌症研究機構 (IARC) 估計，2021 年全球癌症負擔將增加，新增病例約 190 萬例，預計到 2040 年將新增 2750 萬例因此，這一因素正在推動個性化藥物開發的需求，從而導致市場成長，對生物製劑和生物相似藥的需求正在推動哺乳動物細胞發酵技術的市場。這些療法對於解決許多疾病至關重要，例如癌症、自體免疫疾病和各種慢性疾病。 2022 年5 月，Biocon Biologics Ltd. 和Viatris Inc. 的Abevmy（貝伐珠單抗）獲得加拿大衛生部的批准，Abevmy（貝伐珠單抗）是羅氏Avastin（貝伐珠單抗）的生物學名藥，適用於四種癌症適應症。因此，生物製劑和生物相似藥的不斷發展正在推動市場成長。此外，不斷進步的技術進步以及製藥公司不斷增加的研發支出正在為市場創造新的機會。然而，與技術開發相關的高成本正在限制 2023-2030 年預測期內的市場成長。

全球哺乳動物細胞發酵技術市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲以及中東和非洲。由於該地區強大的生物製藥行業影響力、支持性的政府法規以及發達的醫療保健基礎設施，北美將在 2022 年佔據市場主導地位，佔據最大的市場佔有率。此外，對生物製品和生物相似藥的需求增加以及慢性病盛行率的上升也促進了該地區市場的擴張。由於患者人數眾多、對生物藥品的需求不斷增加、政府支持生物技術研究和開發的舉措以及合約製造組織 (CMO) 的成長等因素，預計亞太地區將在預測期內成為成長最快的地區。該地區正在推動這一擴張。

研究的目的是確定近年來不同細分市場和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家內該行業的定性和定量方面。

該報告還提供了有關促進因素和挑戰等關鍵方面的詳細資訊，這些因素將決定市場的未來成長。此外，它還涵蓋了利害關係人投資的微觀市場的潛在機會，以及對主要參與者的競爭格局和產品供應的詳細分析。

目錄

第 1 章：執行摘要

  • 市場概況
  • 2020-2030 年全球與細分市場估計與預測
    • 2020-2030 年哺乳動物細胞發酵技術市場（按地區）
    • 2020-2030 年哺乳動物細胞發酵技術市場（按類型）
    • 2020-2030 年哺乳動物細胞發酵技術市場（按應用）
    • 哺乳動物細胞發酵技術市場（按最終用途），2020-2030 年
  • 主要趨勢
  • 估算方法
  • 研究假設

第 2 章：全球哺乳動物細胞發酵技術市場定義與範圍

  • 研究目的
  • 市場定義和範圍
    • 產業演變
    • 研究範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球哺乳動物細胞發酵技術市場動態

  • 哺乳動物細胞發酵技術市場影響分析（2020-2030）
    • 市場促進因素
      • 慢性病盛行率不斷上升
      • 對新穎且安全的療法的需求不斷增加
      • 對生物製劑和生物相似藥的需求不斷成長
    • 市場挑戰
      • 哺乳動物細胞發酵技術成本高
      • 嚴格的政府法規
    • 市場機會
      • 技術進步
      • 增加研發支出

第 4 章：全球哺乳動物細胞發酵技術市場：產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
  • 波特的五力影響分析
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • COVID-19 影響分析
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球哺乳動物細胞發酵技術市場（按類型）

  • 市場概況
  • 全球哺乳動物細胞發酵技術市場按類型、性能-潛力分析
  • 2020-2030 年全球哺乳動物細胞發酵技術市場估計與預測（按類型）
  • 哺乳動物細胞發酵技術市場細分分析
    • 倉鼠卵巢 (CHO) 細胞發酵
    • 人類胚胎腎 (HEK) 細胞發酵
    • 小倉鼠腎 (BHK) 細胞發酵
    • 鼠骨髓瘤細胞發酵
    • 其他

第 6 章：全球哺乳動物細胞發酵技術市場（按應用）

  • 市場概況
  • 全球哺乳動物細胞發酵技術市場按應用、性能-潛力分析
  • 2020-2030 年全球哺乳動物細胞發酵技術市場估計及應用預測
  • 哺乳動物細胞發酵技術市場細分分析
    • 單株抗體
    • 重組蛋白
    • 疫苗
    • 荷爾蒙
    • 酵素
    • 其他

第 7 章：全球哺乳動物細胞發酵技術市場（依最終用途）

  • 市場概況
  • 全球哺乳動物細胞發酵技術市場（依最終用途、性能）-潛力分析
  • 2020-2030 年全球哺乳動物細胞發酵技術市場估計與最終用途預測
  • 哺乳動物細胞發酵技術市場細分分析
    • 生物製藥公司
    • CMO 和 CDMO
    • 學術及研究機構

第 8 章：全球哺乳動物細胞發酵技術市場，區域分析

  • 領先國家
  • 頂尖新興國家
  • 哺乳動物細胞發酵技術市場，區域市場概況
  • 北美洲
    • 美國
      • 2020-2030 年型別細分估計與預測
      • 2020-2030 年應用細分估計與預測
      • 2020-2030 年最終用途細分估計與預測
    • 加拿大
  • 歐洲哺乳動物細胞發酵技術市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太哺乳動物細胞發酵技術市場概況
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲哺乳動物細胞發酵技術市場概況
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章：競爭情報

  • 重點企業SWOT分析
    • 公司1
    • 公司2
    • 公司3
  • 頂級市場策略
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 最近的發展
    • Merck KGaA
    • Danaher Corporation
    • Lonza Group
    • Hoffmann-La Roche Ltd
    • Sartorius AG
    • AstraZeneca
    • Bristol-Myers Squibb
    • Amgen Inc.
    • Gilead Sciences Inc.

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Mammalian Cell Fermentation Technology Market is valued at approximately USD 39.49 billion in 2022 and is anticipated to grow with a growth rate of more than 8.64% over the forecast period 2023-2030. Mammalian cell fermentation, is widely used to create a variety of biosimilars, enzymes, vaccines, and other biologics. It is an essential step in the development of biopharmaceuticals. Mammalian cells are cultured in a bioreactor for fermentation after being produced in vitro from stem cells. The essential byproducts are produced during this process by the cells using a variety of metabolic pathways. The market for Mammalian Cell Fermentation Technology is driven due to factors such as growing prevalence of chronic diseases, growing need for novel and secure therapies and the growing demand for biologics and biosimilars.

Additionally, the rising prevalence of various chronic diseases including cancer is driving the market growth as cancer treatment often involves the use of biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. Mammalian cell fermentation is a crucial method for producing these complex biologics. The demand for biologics rises due to the rising prevalence of cancer, which, in turn, drives the need for mammalian cell fermentation technology. According to the International Agency for Research on Cancer (IARC), it is estimated that there was an increase in the global burden of cancer in 2021 approximately 1.9 million new cases have been recorded, which is projected to account for 27.5 million new cases by 2040. Thus, this factor is propelling the demand for the development of personalized medicines, resulting in market growth, The demand for biologics and biosimilars is driving the market for mammalian cell fermentation technology. These therapies are essential for addressing a number of disorders, such as cancer, autoimmune diseases, and various chronic diseases. In May 2022, Biocon Biologics Ltd. and Viatris Inc. received approval from Health Canada for Abevmy (bevacizumab), a biosimilar to Roche's Avastin (bevacizumab), across four cancer indications. Consequentially, the rising development of biologics and biosimilars is driving market growth. Furthermore, rising technological advancement, as well as the increasing research and development spending by pharmaceutical companies are creating new opportunities to the market. However, the high cost associated with the development of technology is restraining the market growth in the forecast period 2023-2030.

The key regions considered for the Global Mammalian Cell Fermentation Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the region's strong biopharmaceutical industry presence, supportive government regulations, and well-developed healthcare infrastructure. Additionally, the increased demand for biologics and biosimilars as well as the rising prevalence of chronic diseases have contributed to the expansion of the market in the region. Asia Pacific is expected to a fastest growing region during the forecast period, owing to factors such as a big patient population, increasing demand for biologic pharmaceuticals, government initiatives to support biotechnology research and development, and a growth in contract manufacturing organizations (CMOs) in the region, are driving this expansion.

Major market player included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen Inc.
  • Gilead Sciences Inc.

Recent Developments in the Market:

  • In January 2023, Fosun Pharma and Shanghai Henlius Biotech announced their agreement for the marketing of serplulimab, an anti-PD-1 monoclonal antibody . The agreement is anticipated to broaden Fosun Pharma's biologics portfolio, as well as its manufacturing and development capabilities, in this quickly expanding market.

Global Mammalian Cell Fermentation Technology Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Application, End Use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

By Application:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Others

By End Use:

  • Biopharmaceutical Companies
  • CMOs & CDMOs
  • Academic & Research Institutes

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Mammalian Cell Fermentation Technology Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Mammalian Cell Fermentation Technology Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Mammalian Cell Fermentation Technology Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Mammalian Cell Fermentation Technology Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Mammalian Cell Fermentation Technology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Mammalian Cell Fermentation Technology Market Dynamics

  • 3.1. Mammalian Cell Fermentation Technology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Increasing need for novel and secure therapies
      • 3.1.1.3. Growing demand for biologics and biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of mammalian cell fermentation technology
      • 3.1.2.2. Stringent government regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancement
      • 3.1.3.2. Increasing research and development spending

Chapter 4. Global Mammalian Cell Fermentation Technology Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Mammalian Cell Fermentation Technology Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Mammalian Cell Fermentation Technology Market by Type, Performance - Potential Analysis
  • 5.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 5.4.1. Hamster Ovary (CHO) Cell Fermentation
    • 5.4.2. Human Embryonic Kidney (HEK) Cell Fermentation
    • 5.4.3. Baby Hamster Kidney (BHK) Cell Fermentation
    • 5.4.4. Murine Myeloma Cell Fermentation
    • 5.4.5. Others

Chapter 6. Global Mammalian Cell Fermentation Technology Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Mammalian Cell Fermentation Technology Market by Application, Performance - Potential Analysis
  • 6.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibodies
    • 6.4.2. Recombinant Proteins
    • 6.4.3. Vaccines
    • 6.4.4. Hormones
    • 6.4.5. Enzymes
    • 6.4.6. Others

Chapter 7. Global Mammalian Cell Fermentation Technology Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Mammalian Cell Fermentation Technology Market by End Use, Performance - Potential Analysis
  • 7.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 7.4.1. Biopharmaceutical Companies
    • 7.4.2. CMOs & CDMOs
    • 7.4.3. Academic & Research Institutes

Chapter 8. Global Mammalian Cell Fermentation Technology Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Mammalian Cell Fermentation Technology Market, Regional Market Snapshot
  • 8.4. North America Mammalian Cell Fermentation Technology Market
    • 8.4.1. U.S. Mammalian Cell Fermentation Technology Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Mammalian Cell Fermentation Technology Market
  • 8.5. Europe Mammalian Cell Fermentation Technology Market Snapshot
    • 8.5.1. U.K. Mammalian Cell Fermentation Technology Market
    • 8.5.2. Germany Mammalian Cell Fermentation Technology Market
    • 8.5.3. France Mammalian Cell Fermentation Technology Market
    • 8.5.4. Spain Mammalian Cell Fermentation Technology Market
    • 8.5.5. Italy Mammalian Cell Fermentation Technology Market
    • 8.5.6. Rest of Europe Mammalian Cell Fermentation Technology Market
  • 8.6. Asia-Pacific Mammalian Cell Fermentation Technology Market Snapshot
    • 8.6.1. China Mammalian Cell Fermentation Technology Market
    • 8.6.2. India Mammalian Cell Fermentation Technology Market
    • 8.6.3. Japan Mammalian Cell Fermentation Technology Market
    • 8.6.4. Australia Mammalian Cell Fermentation Technology Market
    • 8.6.5. South Korea Mammalian Cell Fermentation Technology Market
    • 8.6.6. Rest of Asia Pacific Mammalian Cell Fermentation Technology Market
  • 8.7. Latin America Mammalian Cell Fermentation Technology Market Snapshot
    • 8.7.1. Brazil Mammalian Cell Fermentation Technology Market
    • 8.7.2. Mexico Mammalian Cell Fermentation Technology Market
  • 8.8. Middle East & Africa Mammalian Cell Fermentation Technology Market
    • 8.8.1. Saudi Arabia Mammalian Cell Fermentation Technology Market
    • 8.8.2. South Africa Mammalian Cell Fermentation Technology Market
    • 8.8.3. Rest of Middle East & Africa Mammalian Cell Fermentation Technology Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Thermo Fisher Scientific, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Merck KGaA
    • 9.3.3. Danaher Corporation
    • 9.3.4. Lonza Group
    • 9.3.5. Hoffmann-La Roche Ltd
    • 9.3.6. Sartorius AG
    • 9.3.7. AstraZeneca
    • 9.3.8. Bristol-Myers Squibb
    • 9.3.9. Amgen Inc.
    • 9.3.10. Gilead Sciences Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Mammalian Cell Fermentation Technology Market, report scope
  • TABLE 2. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 71. List of primary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Mammalian Cell Fermentation Technology Market, research methodology
  • FIG 2. Global Mammalian Cell Fermentation Technology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Mammalian Cell Fermentation Technology Market, key trends 2022
  • FIG 5. Global Mammalian Cell Fermentation Technology Market, growth prospects 2023-2030
  • FIG 6. Global Mammalian Cell Fermentation Technology Market, porters 5 force model
  • FIG 7. Global Mammalian Cell Fermentation Technology Market, pest analysis
  • FIG 8. Global Mammalian Cell Fermentation Technology Market, value chain analysis
  • FIG 9. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Mammalian Cell Fermentation Technology Market, regional snapshot 2020 & 2030
  • FIG 15. North America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable